FBRX · Categories · Form 4

FBRX - SEC Form 4 insider transactions

Forte Biosciences Inc. (FBRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for FBRX

• 1d
  SEC Form 4 filed by Director Doberstein Stephen K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 1d
  SEC Form 4 filed by Director Kapoor Shivpreet Singh

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 1d
  SEC Form 4 filed by Director Vincent Richard G

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 1d
  SEC Form 4 filed by Director Gryska David W

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 1d
  SEC Form 4 filed by Director Brun Scott C.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 1d
  SEC Form 4 filed by Director Kornfeld Steven

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 61d
  SEC Form 4 filed by Riley Antony A

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 61d
  SEC Form 4 filed by Wagner Paul A.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 141d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Riley Antony A

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 141d
  SEC Form 4 filed by Officer Wagner Paul A.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 152d
  Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 164 shares, increasing direct ownership by 1% to 83,178 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 244d
  CHIEF FINANCIAL OFFICER Riley Antony A covered exercise/tax liability with 134 shares and converted options into 375 shares, increasing direct ownership by 0.76% to 31,840 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 244d
  Officer Wagner Paul A. covered exercise/tax liability with 98 shares and converted options into 1,250 shares, increasing direct ownership by 1% to 82,092 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 335d
  CHIEF FINANCIAL OFFICER Riley Antony A converted options into 375 shares and covered exercise/tax liability with 134 shares, increasing direct ownership by 0.77% to 31,599 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 335d
  Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 98 shares, increasing direct ownership by 1% to 80,940 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 427d
  CHIEF FINANCIAL OFFICER Riley Antony A converted options into 375 shares and covered exercise/tax liability with 154 shares, increasing direct ownership by 0.71% to 31,218 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 427d
  Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 18 shares, increasing direct ownership by 2% to 79,788 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 439d
  SEC Form 4 filed by Director Gryska David W

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 439d
  SEC Form 4 filed by Director Vincent Richard G

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 439d
  SEC Form 4 filed by Director Kapoor Shivpreet Singh

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 439d
  SEC Form 4 filed by Director Doberstein Stephen K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 439d
  SEC Form 4 filed by Director Brun Scott C.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 439d
  SEC Form 4 filed by Director Kornfeld Steven

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 439d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Riley Antony A

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 439d
  SEC Form 4 filed by Officer Wagner Paul A.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 439d
  SEC Form 4 filed by Director Finck Barbara K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 517d
  CHIEF FINANCIAL OFFICER Riley Antony A converted options into 375 shares and covered exercise/tax liability with 154 shares, increasing direct ownership by 0.72% to 30,997 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 517d
  Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 164 shares, increasing direct ownership by 1% to 78,556 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 609d
  CHIEF FINANCIAL OFFICER Riley Antony A covered exercise/tax liability with 133 shares and converted options into 375 shares, increasing direct ownership by 3% to 8,262 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 609d
  Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 98 shares, increasing direct ownership by 2% to 77,470 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 622d
  SEC Form 4 filed by Director Kapoor Shivpreet Singh

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 622d
  SEC Form 4 filed by Director Vincent Richard G

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 650d
  SEC Form 4 filed by Director Eichenfield Lawrence

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 650d
  SEC Form 4 filed by Director Gryska David W

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 650d
  SEC Form 4 filed by Director Kornfeld Steven

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 650d
  SEC Form 4 filed by Director Doberstein Stephen K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 650d
  SEC Form 4 filed by Director Finck Barbara K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 650d
  SEC Form 4 filed by Director Williams Donald Allen

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 650d
  SEC Form 4 filed by Director Brun Scott C.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 700d
  CHIEF FINANCIAL OFFICER Riley Antony A converted options into 9,375 shares and covered exercise/tax liability with 3,345 shares, increasing direct ownership by 3% to 200,504 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 700d
  Officer Wagner Paul A. converted options into 31,250 shares and covered exercise/tax liability with 2,453 shares, increasing direct ownership by 2% to 1,907,971 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 792d
  Riley Antony A converted options into 9,375 shares and covered exercise/tax liability with 3,345 shares, increasing direct ownership by 3% to 194,474 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 792d
  Wagner Paul A. converted options into 31,250 shares and covered exercise/tax liability with 2,453 shares, increasing direct ownership by 2% to 1,879,174 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 800d
  SEC Form 4 filed by Finck Barbara K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 800d
  SEC Form 4 filed by Riley Antony A

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 800d
  SEC Form 4 filed by Wagner Paul A.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 882d
  Chen Hubert C converted options into 7,500 shares and covered exercise/tax liability with 3,073 shares, increasing direct ownership by 5% to 93,405 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 882d
  Riley Antony A converted options into 9,375 shares and covered exercise/tax liability with 3,841 shares, increasing direct ownership by 3% to 188,444 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 882d
  Wagner Paul A. converted options into 31,250 shares and covered exercise/tax liability with 4,109 shares, increasing direct ownership by 1% to 1,850,377 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 974d
  Chen Hubert C converted options into 7,500 shares and covered exercise/tax liability with 2,593 shares, increasing direct ownership by 6% to 88,978 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 974d
  Riley Antony A converted options into 9,375 shares and covered exercise/tax liability with 3,241 shares, increasing direct ownership by 3% to 182,910 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 974d
  Wagner Paul A. covered exercise/tax liability with 2,453 shares and converted options into 31,250 shares, increasing direct ownership by 2% to 1,704,371 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 987d
  SEC Form 4 filed by Brun Scott C.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 987d
  SEC Form 4 filed by Williams Donald Allen

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 987d
  SEC Form 4 filed by Kornfeld Steven

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 987d
  SEC Form 4 filed by Gryska David W

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 987d
  SEC Form 4 filed by Finck Barbara K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 987d
  SEC Form 4 filed by Eichenfield Lawrence

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 987d
  SEC Form 4 filed by Doberstein Stephen K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 1036d
  SEC Form 4: Kornfeld Steven was granted 99,009 shares

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)

Other FBRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends